Onconetix, Inc. (ONCO) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 1 Buy, 1 Hold.
Analysts estimate Earnings Per Share (EPS) of $-14,450.00 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-520.93 vs est $-14,450.00 (beat +96.4%). 2025: actual $-4.73 vs est $-16,830.00 (beat +100%). Analyst accuracy: 0%.
ONCO Analyst Ratings
Buy
Based on 2 analysts giving stock ratings to Onconetix, Inc. in the past 3 months
EPS Estimates — ONCO
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$520.93
vs Est –$14,450.00
▲ 2,673.9% off
2025
Actual –$4.73
vs Est –$16,830.00
▲ 355,714.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — ONCO
66%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.003B
vs Est $0.001B
▲ 68.3% off
2025
Actual $0.001B
vs Est $0.001B
▼ 0.0% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
